Elanco Animal Health Incorporated Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year
Elanco Animal Health Incorporated (ELAN) had Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year of $11.00 million as of 2022-12-31, per its 10-K filed 2023-03-01.
Discontinued › Notes › Defined Benefit Plan
us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear · last filed 2023-03-01
- 2022-12-31: Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year $11.00M.
- 2021-12-31: Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year $10.00M.
- 2020-12-31: Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year $18.10M.
- 2019-12-31: Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year $6.50M.
| Period end | Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year |
|---|---|
| 2022-12-31 | $11.00M 10-K · filed 2023-03-01 |
| 2021-12-31 | $10.00M 10-K · filed 2022-02-28 |
| 2020-12-31 | $18.10M 10-K · filed 2021-03-01 |
| 2019-12-31 | $6.50M 10-K · filed 2020-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |